Pfizer-BioNTech
Sri Lanka has approved the Pfizer-BioNTech COVID-19 vaccine for emergency use and prepared a purchase order for five million doses, an official said.
State Minister Sudarshini Fernandopulle’s media secretary confirmed to EconomyNext that the National Medicines Regulatory Authority (NMRA) granted its approval for the jab on Friday.
The Pfizer-BioNTech vaccine is one of the two pioneering jabs the World Health Organisation (WHO) approved for emergency use, the other being the Oxford-AstaZeneca vaccine that Sri Lanka used to inoculate some 900,000 people including frontline workers.
The WHO approved the Pfizer jab for emergency use on December 31 last year.
The vaccine is produced by the US-based Pfizer pharmaceutical company and has shown the efficacy of 95 per cent against symptomatic SARS-CoV-2 virus.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
